Beacon

We are the targeted therapies clinical trial and drug development database solution made in collaboration with biopharma, for biopharma.

[Beacon @BeaconIntel]

📊 Explore the dynamic landscape of immune-mediated therapies and stay at the forefront of groundbreaking developments. Download your copy now: https://t.co/jAy3L7uLtn

[Beacon @BeaconIntel]

🔍 Curious about the gene therapy landscape in 2023? 🌱 Explore part 2 of our 2023 Landscape Series for an in-depth analysis of trial changes in 2023, terminations and regulatory announcements. Download now! https://t.co/H4FR0uA878 #GeneTherapyInsights #2023Analysis #2023Review

[Beacon @BeaconIntel]

📈 Keep your finger on the pulse of gene therapy innovations! 💡 The Annual 2023 Landscape Review is out now, offering a comprehensive look at the latest changes. Download Part 1 of the series and stay informed! https://t.co/H4FR0uA878 #GeneTherapyInnovation #2023Review

[Beacon @BeaconIntel]

The first part of our 2023 Immune Tolerance Landscape Review is available for download. 📊 Stay informed on the latest immune-mediated therapies – assets, mechanisms, and more. Your key to staying ahead is expanding the field rapidly. Get your copy: https://t.co/jAy3L7uLtn

[Beacon @BeaconIntel]

🔓 Unlock exciting insights from ESMO 2023! Our Post-Conference Report summarizes the 41 cytokine-related abstracts presented. Find out how new developments are transforming treatments for solid tumors, lung cancer, and more! Download your copy: https://t.co/ms1tE24cvQ

#ESMO

[Beacon @BeaconIntel]

🧪The Checkpoint Disease Landscape delves into the dynamic world of ICMs and centers on the top 5 oncology disease indications across drugs and trials.

This Report is your essential guide to the future of checkpoint therapies. Download here: https://t.co/2uSP4k4I0r

#Oncology

[Beacon @BeaconIntel]

🔎 Curious about the exciting insights shared at ESMO? Dive into our Post-Conference Report to explore the top drug assets, trial phases, and disease indications, plus a summary of all 333 abstracts presented at the event. Download the report today! https://t.co/MK0EQgZ91a

#ESMO

[Beacon @BeaconIntel]

Our brand new report, The Preclinical Cytokine Review provides crucial insights into:
🎯 Top Targets including IL-2, IL-15, and IL-12
🔬 Disease Indications
🐭 Preclinical Models
📣 IND Approvals
Download here: https://t.co/jVhHP7AAhL
#Cytokines #DrugDevelopment #PreclinicalData

[Beacon @BeaconIntel]

📈 Of the 804 ADCs currently in preclinical development, 71% are classed as active, showing evidence of continued development and instilling confidence for the future.

Discover top targets, moiety formats and more in our infographic: https://t.co/YblTfF064x

#Preclinical #ADCs

[Beacon @BeaconIntel]

💊The preclinical ADC landscape is experiencing impressive growth but the is also facing a shift as popular target HER-2 begins to decline and two promising targets climb the ranks.

Download our infographic to reveal top targets and more… https://t.co/YblTfF0DU5

#ADCs #HER2

[Beacon @BeaconIntel]

Empower your drug development with Beacon Cell Therapy. Our comprehensive database of +5800 drugs and +4700 trials provides accurate, timely, and exhaustive data for informed decision-making. #DataDrivenSolutions #CellTherapies https://t.co/GzCod8meSl

[Beacon @BeaconIntel]

📗 The Cancer Vaccine ASCO Post-Conference Report 2023 is here to download https://t.co/35AS1feSzt. Access detailed insights on the abstract analysis broken down by data type, therapeutic class, and trial phase, also clinical, trial outline, and preclinical abstract summaries.

[Beacon @BeaconIntel]

📗 The OV ASCO Post-Conference Report 2023 is here to download https://t.co/gRCvcMTy4c. Access detailed insights on the abstract analysis broken down by data type, viral family, and clinical abstract properties also clinical, trial outline, and preclinical abstract summaries.

[Beacon @BeaconIntel]

📈 The number of cytokine-armored cell therapy trials has accelerated since 2019 and the field shows huge potential! Our report highlights the top 10 cytokine-armoring strategies, trends in recent trials and more!

Download the report here: https://t.co/nM2uOvzkmV

#celltherapies

[Beacon @BeaconIntel]

Cytokine-armored cell therapies are climbing in popularity! With trials increasing year-on-year since 2019, it is imperative to stay informed on this emerging landscape.

📥 Download the free report for expert analysis: https://t.co/nM2uOvzkmV

#celltherapies #drugdevelopment

[Beacon @BeaconIntel]

🚨Cancer Vaccine AACR Post-Conference Report Released https://t.co/2Q4GAaHsRj
View the in-depth analysis of 54 cancer vaccine-relevant abstracts, including 26 clinical and 28 preclinical.

#aacr23
#cancervaccine
#report

[Beacon @BeaconIntel]

🚨Adoptive Cell AACR Post-Conference Report Released https://t.co/uECZnuHlCs🚨

View the in-depth analysis of 107 adoptive cell-relevant abstracts, including 21 clinical and 86 preclinical.

#aacr2023
#adoptivecell
#REPORT

[Beacon @BeaconIntel]

🚨Oncolytic Viruses AACR Post-Conference Report Released https://t.co/oTfLmUFxZZ🚨

View the in-depth analysis of 39 oncolytic viruses-relevant abstracts, including 13 clinical and 26 preclinical.

#aacr23
#oncology
#report

[Beacon @BeaconIntel]

Our latest infographic on the hot topic Neoantigen Cancer Vaccines is free to download here https://t.co/ZDo3HB5R00

Find out more by downloading the infographic.

#cancervaccine
#infographic
#neoantigen

[Beacon @BeaconIntel]

📢 The AACR 2023 Annual Meeting begins tomorrow! Prepare your schedule using our Cytokine Pre-Conference Planner that lists 149 abstracts.

View the Planner here: https://t.co/ZPPYbKI8sg

#cytokine #AACR #AACR2023 #drugdevelopment